Russell Frank Company’s Ionis Pharmaceuticals IONS Stock Holding History

Russell Frank Company’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$1.35M	Buy	33,395 +3,663	+12%	+$149K	﹤0.01%	2039
2015 Q4	$1.82M	Sell	29,732 -55,070	-65%	-$2.97M	﹤0.01%	1882
2015 Q3	$3.43M	Sell	84,802 -10,158	-11%	-$526K	0.01%	1509
2015 Q2	$5.46M	Buy	94,960 +20,768	+28%	+$1.32M	0.01%	1360
2015 Q1	$4.72M	Buy	74,192 +9,416	+15%	+$639K	0.01%	1297
2014 Q4	$4M	Buy	64,776 +6,600	+11%	+$326K	0.01%	1428
2014 Q3	$2.26M	Hold	58,176	–	–	﹤0.01%	1679
2014 Q2	$1.81M	Buy	58,176 +36,249	+165%	+$1.14M	﹤0.01%	1808
2014 Q1	$704K	Buy	21,927 +14,647	+201%	+$710K	﹤0.01%	2239
2013 Q4	$360K	Sell	7,280 -17,729	-71%	-$632K	﹤0.01%	2446
2013 Q3	$938K	Sell	25,009 -2,754	-10%	-$82.3K	﹤0.01%	2216
2013 Q2	$746K	Buy	+27,763	New	+$590K	﹤0.01%	2183

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Russell Frank Company's IONS Position: Q1 2016 in Review

Russell Frank Company increased its Ionis Pharmaceuticals (IONS) stake by 12% in Q1 2016, buying an estimated $149K and bringing the position to 33,395 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

Russell Frank Company first reported a position in IONS in Q2 2013 and has held it in 12 quarters since. The position peaked at $5.46M in Q2 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q1 2016.

Russell Frank Company held 33,395 shares of Ionis Pharmaceuticals worth $1.35M as of Q1 2016.
Russell Frank Company bought 3,663 Ionis Pharmaceuticals shares in Q1 2016, an estimated $149K.
Ionis Pharmaceuticals made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2039 holding.
Russell Frank Company first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Ionis Pharmaceuticals position peaked at $5.46M in Q2 2015.
314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.